Monthly Archives: March 2010
Avandia Drug Maker Accused of Funding Scientists to Distort Information
Avandia Supporters Had Financial Ties to Maker of Dangerous Type 2 Diabetes Drug The controversy over type 2 diabetes drug Avandia has been ongoing since 2007. However, researchers from the prestigious Mayo Clinic believe they may have found the cause … Continue reading
Plavix Linked to Increased Risk of Heart Attack in Some Patients
The FDA Issues a Black Box Warning: Plavix May Lead to Heart Attack / Stroke in Some Patients This morning, the FDA issued a black box warning in regards to Plavix, one of the most popular blood thinners prescribed to … Continue reading
African American’s At Risk of Heart Attacks and Strokes on Plavix
Bristol Myers Squibb and Sanofi which co-promote and market Plavix (Clopidogrel Bisulfate) is under fire again. Last time, it was for drug Plavix causing Thrombotic thrombocytopenic purpura (TTP), a typically rare yet very serious and potentially fatal condition where blood … Continue reading
DePuy ASR Hip Implants Claim – DePuy ASR Lawsuits
DePuy ASR hip implants failure rates higher than normal often requiring revision surgery DePuy Orthopaedics has halted sales of its ASR hip implant. The ARS device, one of several models sold by DePuy — the orthopedic arm of Johnson & … Continue reading
Fosamax Linked to Femur Fractures
Doctors Report Increase in Femur Fractures Among Patients Taking Fosamax for Osteoporosis In addition to previously observed side effects of Fosamax, including osteonecrosis of the jaw, headache, nausea and rashes, doctors now report an increasing incidence of femur fractures among … Continue reading
Study Finds Link Between Tricholorethylene (TCE) and Parkinson’s
Tricholorethylene (TCE) Exposure Increases Risk of Parkinson’s Disease Exposure to the industrial chemical tricholorethylene (TCE) is associated with a higher risk of developing Parkinson’s disease, according to a new study. TCE is a solvent once widely used in dry cleaning … Continue reading
Fosamax found to weaken bones rather than strengthen them
Doctors are reporting increases in unusual bone fractures over the past 18 months in patients taking the Merck osteoporosis drug Fosamax (alendronate). As pressure increases for the Merck or the FDA to act, doctors say they are seeing more patients … Continue reading
DePuy halts ASR hip implant much too late
After more than two years of problem reports, DePuy Orthopaedics finally decided to withdraw its ASR hip implants from the market, because the ASR hip implant was failing in traditional hip replacements only a few years after implant, requiring costly … Continue reading
California county files Avandia class action against GSK
A California county has filed a class action lawsuit against Avandia-maker GlaxoSmithKline (GSK), claiming GSK hid evidence that Avandia increases the risk of heart attacks. County officials in Santa Clara County, in northern California, say they believe this is the … Continue reading
Dr. Steven Nissen affirms Avandia risks
The doctor that helped focus scientific scrutiny on the heart dangers of Avandia says the diabetes drug remains controversial. “Many physicians have stopped prescribing Avandia,” Dr. Nissen said. Dr. Nissen points out, in a recent US News column, that the … Continue reading